| Year |
Citation |
Score |
| 2020 |
Hjorth S, Waters S, Waters N, Tedroff J, Svensson P, Fagerberg A, Edling M, Svanberg B, Ljung E, Gunnergren J, McLean SL, Grayson B, Idris NF, Neill JC, Sonesson C. . The Journal of Pharmacology and Experimental Therapeutics. PMID 32605972 DOI: 10.1124/jpet.120.000037 |
0.38 |
|
| 2020 |
Waters S, Sonesson C, Svensson P, Tedroff J, Carta M, Ljung E, Gunnergren J, Edling M, Svanberg B, Fagerberg A, Kullingsjo J, Hjorth S, Waters N. Preclinical pharmacology of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine (IRL790), a novel dopamine transmission modulator for the treatment of motor and psychiatric complications in Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics. PMID 32358046 DOI: 10.1124/Jpet.119.264226 |
0.503 |
|
| 2020 |
Jansson-Löfmark R, Hjorth S, Gabrielsson J. Does in vitro potency predict clinical efficacious concentrations? Clinical Pharmacology and Therapeutics. PMID 32275768 DOI: 10.1002/cpt.1846 |
0.303 |
|
| 2016 |
Hjorth S. Looking back (and in)to the future: A personal reflection on 'Serotonin autoreceptor function and antidepressant drug action' (Hjorth et al., 2000). Journal of Psychopharmacology (Oxford, England). PMID 27166363 DOI: 10.1177/0269881116647621 |
0.402 |
|
| 2015 |
Walsh SK, Hepburn CY, Keown O, Åstrand A, Lindblom A, Ryberg E, Hjorth S, Leslie SJ, Greasley PJ, Wainwright CL. Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach. Pharmacology Research & Perspectives. 3: e00143. PMID 26236485 DOI: 10.1002/prp2.143 |
0.426 |
|
| 2015 |
Hjorth S, Karlsson C, Jucaite A, Varnäs K, Wählby Hamrén U, Johnström P, Gulyás B, Donohue SR, Pike VW, Halldin C, Farde L. A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates. Neuropharmacology. PMID 25791528 DOI: 10.1016/J.Neuropharm.2015.03.002 |
0.406 |
|
| 2015 |
Karlsson C, Hjorth S, Karpefors M, Hansson GI, Carlsson B. Baseline anandamide levels and body weight impact the weight loss effect of CB1 receptor antagonism in male rats. Endocrinology. 156: 1237-41. PMID 25549047 DOI: 10.1210/en.2014-1730 |
0.319 |
|
| 2014 |
Skowronski AA, Morabito MV, Mueller BR, Lee S, Hjorth S, Lehmann A, Watanabe K, Zeltser LM, Ravussin Y, Rosenbaum M, LeDuc CA, Leibel RL. Effects of a novel MC4R agonist on maintenance of reduced body weight in diet-induced obese mice. Obesity (Silver Spring, Md.). 22: 1287-95. PMID 24318934 DOI: 10.1002/Oby.20678 |
0.325 |
|
| 2011 |
Wennerberg M, Cheng L, Hjorth S, Clapham JC, Balendran A, Vauquelin G. Binding properties of antagonists to cannabinoid receptors in intact cells. Fundamental & Clinical Pharmacology. 25: 200-10. PMID 20608998 DOI: 10.1111/j.1472-8206.2010.00843.x |
0.338 |
|
| 2010 |
Boström J, Olsson RI, Tholander J, Greasley PJ, Ryberg E, Nordberg H, Hjorth S, Cheng L. Novel thioamide derivatives as neutral CB1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20: 479-82. PMID 20005704 DOI: 10.1016/j.bmcl.2009.11.125 |
0.371 |
|
| 2005 |
Ryberg E, Vu HK, Larsson N, Groblewski T, Hjorth S, Elebring T, Sjögren S, Greasley PJ. Identification and characterisation of a novel splice variant of the human CB1 receptor. Febs Letters. 579: 259-64. PMID 15620723 DOI: 10.1016/j.febslet.2004.11.085 |
0.381 |
|
| 2003 |
Felton TM, Kang TB, Hjorth S, Auerbach SB. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. Naunyn-Schmiedeberg's Archives of Pharmacology. 367: 297-305. PMID 12644903 DOI: 10.1007/S00210-002-0688-X |
0.46 |
|
| 2001 |
Wikell C, Kugelberg FC, Hjorth S, Apelqvist G, Bengtsson F. Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy. Clinical Neuropharmacology. 24: 324-33. PMID 11801807 DOI: 10.1097/00002826-200111000-00003 |
0.355 |
|
| 2001 |
Wikell C, Hjorth S, Apelqvist G, Kullingsjö J, Lundmark J, Bergqvist PB, Bengtsson F. Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings. Naunyn-Schmiedeberg's Archives of Pharmacology. 363: 448-55. PMID 11330339 DOI: 10.1007/s002100100405 |
0.314 |
|
| 2000 |
Apelqvist G, Wikell C, Carlsson B, Hjorth S, Bergqvist PB, Ahlner J, Bengtsson F. Dynamic and kinetic effects of chronic citalopram treatment in experimental hepatic encephalopathy. Clinical Neuropharmacology. 23: 304-17. PMID 11575864 DOI: 10.1097/00002826-200011000-00003 |
0.433 |
|
| 2000 |
Bengtsson HJ, Kele J, Johansson J, Hjorth S. Interaction of the antidepressant mirtazapine with alpha2-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology. 362: 406-12. PMID 11111835 DOI: 10.1007/s002100000294 |
0.43 |
|
| 2000 |
Hjorth S, Bengtsson HJ, Kullberg A, Carlzon D, Peilot H, Auerbach SB. Serotonin autoreceptor function and antidepressant drug action. Journal of Psychopharmacology (Oxford, England). 14: 177-85. PMID 10890313 DOI: 10.1177/026988110001400208 |
0.453 |
|
| 1999 |
Hjorth S, Auerbach SB. Autoreceptors remain functional after prolonged treatment with a serotonin reuptake inhibitor. Brain Research. 835: 224-8. PMID 10415377 DOI: 10.1016/S0006-8993(99)01585-1 |
0.471 |
|
| 1998 |
Martin P, Carlsson ML, Hjorth S. Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats. Neuroreport. 9: 2985-8. PMID 9804302 DOI: 10.1097/00001756-199809140-00012 |
0.476 |
|
| 1998 |
Bengtsson HJ, Kullberg A, Millan MJ, Hjorth S. The role of 5-HT1A autoreceptors and alpha1-adrenoceptors in the modulation of 5-HT release--III. Clozapine and the novel putative antipsychotic S 16924. Neuropharmacology. 37: 349-56. PMID 9681933 DOI: 10.1016/S0028-3908(98)00017-3 |
0.489 |
|
| 1998 |
Hjorth S, Kullberg A, Millan MJ, Bengtsson HJ. α1-Adrenoceptor/5-hydroxytryptamine (5-HT(1A)) autoreceptor mediation of the 5-HT release-reducing action of clozapine and S16924 in rat ventral hippocampus Nordic Journal of Psychiatry. 52: 126-127. |
0.334 |
|
| 1997 |
Bergqvist PB, Wikell C, Hjorth S, Apelqvist G, Bengtsson F. Effect of citalopram on brain serotonin release in experimental hepatic encephalopathy: implications for thymoleptic drug safety in liver insufficiency. Clinical Neuropharmacology. 20: 511-22. PMID 9403225 DOI: 10.1097/00002826-199712000-00003 |
0.449 |
|
| 1997 |
Bergqvist PB, Hjorth S, Wikell C, Apelqvist G, Bengtsson F. p-Chloroamphetamine- and d-fenfluramine-induced brain serotonin release in experimental portal-systemic encephalopathy. Metabolic Brain Disease. 12: 229-36. PMID 9346471 DOI: 10.1023/B:MEBR.0000007103.82267.06 |
0.442 |
|
| 1997 |
Bergqvist PB, Hjorth S, Apelqvist G, Bengtsson F. Potassium-evoked neuronal release of serotonin in experimental chronic portal-systemic encephalopathy. Metabolic Brain Disease. 12: 193-202. PMID 9346468 DOI: 10.1023/B:MEBR.0000007100.04521.6e |
0.445 |
|
| 1997 |
Gundlah C, Hjorth S, Auerbach SB. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment. Neuropharmacology. 36: 475-82. PMID 9225272 DOI: 10.1016/S0028-3908(97)00052-X |
0.391 |
|
| 1997 |
Hjorth S, Westlin D, Bengtsson HJ. WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor. Neuropharmacology. 36: 461-5. PMID 9225270 DOI: 10.1016/S0028-3908(97)00050-6 |
0.388 |
|
| 1997 |
Millan MJ, Hjorth S, Samanin R, Schreiber R, Jaffard R, De Ladonchamps B, Veiga S, Goument B, Peglion JL, Spedding M, Brocco M. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties. The Journal of Pharmacology and Experimental Therapeutics. 282: 148-61. PMID 9223550 |
0.349 |
|
| 1997 |
Bergqvist PBF, Wikell C, Hjorth S, Apelqvist G, Bengtsson F. Citalopram and release of brain 5-HT in experimental chronic hepatic encephalopathy Biological Psychiatry. 42. DOI: 10.1016/S0006-3223(97)87873-0 |
0.372 |
|
| 1997 |
Bergqvist PBF, Hjorth S, Wikell C, Apelqvist G, Bengtsson F. P-chloroamphetamine- and D-fenfluramine-induced brain 5-HT release in chronic hepatic encephalopathy Biological Psychiatry. 42. DOI: 10.1016/S0006-3223(97)87541-5 |
0.373 |
|
| 1996 |
Bergqvist PB, Hjorth S, Audet RM, Apelqvist G, Bengtsson F, Butterworth RF. Ammonium acetate challenge in experimental chronic hepatic encephalopathy induces a transient increase of brain 5-HT release in vivo. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 6: 317-22. PMID 8985716 DOI: 10.1016/S0924-977X(96)00037-5 |
0.444 |
|
| 1996 |
Hjorth S, Bengtsson HJ, Milano S. Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo. European Journal of Pharmacology. 316: 43-7. PMID 8982649 DOI: 10.1016/S0014-2999(96)00779-0 |
0.451 |
|
| 1996 |
Sharp T, Umbers V, Hjorth S. The role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--II NAN-190 and SDZ 216-525. Neuropharmacology. 35: 735-41. PMID 8887982 DOI: 10.1016/0028-3908(96)84645-4 |
0.364 |
|
| 1996 |
Bergqvist PB, Hjorth S, Apelqvist G, Bengtsson F. Acute effects of L-tryptophan on brain extracellular 5-HT and 5-HIAA levels in chronic experimental portal-systemic encephalopathy. Metabolic Brain Disease. 11: 269-78. PMID 8869946 DOI: 10.1007/Bf02237963 |
0.447 |
|
| 1996 |
Hjorth S. (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine. European Journal of Pharmacology. 303: 183-6. PMID 8813565 DOI: 10.1016/0014-2999(96)00185-9 |
0.464 |
|
| 1996 |
Hjorth S, Auerbach SB. 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI). Behavioural Brain Research. 73: 281-3. PMID 8788519 DOI: 10.1016/0166-4328(96)00113-1 |
0.38 |
|
| 1996 |
Hedberg MH, Linnanen T, Jansen JM, Nordvall G, Hjorth S, Unelius L, Johansson AM. 11-substituted (R)-aporphines: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions. Journal of Medicinal Chemistry. 39: 3503-13. PMID 8784448 DOI: 10.1021/jm960189i |
0.458 |
|
| 1996 |
Hedberg MH, Jansen JM, Nordvall G, Hjorth S, Unelius L, Johansson AM. 10-substituted 11-oxygenated (R)-aporphines: synthesis, pharmacology, and modeling of 5-HT1A receptor interactions. Journal of Medicinal Chemistry. 39: 3491-502. PMID 8784447 DOI: 10.1021/jm960188q |
0.474 |
|
| 1996 |
Vallgårda J, Appelberg U, Arvidsson LE, Hjorth S, Svensson BE, Hacksell U. trans-2-Aryl-N,N-dipropylcyclopropylamines: synthesis and interactions with 5-HT(1A) receptors. Journal of Medicinal Chemistry. 39: 1485-93. PMID 8691479 DOI: 10.1021/jm9507136 |
0.463 |
|
| 1995 |
Auerbach SB, Hjorth S. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology. 352: 597-606. PMID 9053730 DOI: 10.1007/Bf00171317 |
0.51 |
|
| 1995 |
Hedberg MH, Johansson AM, Nordvall G, Yliniemelä A, Li HB, Martin AR, Hjorth S, Unelius L, Sundell S, Hacksell U. (R)-11-hydroxy- and (R)-11-hydroxy-10-methylaporphine: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions. Journal of Medicinal Chemistry. 38: 647-58. PMID 7861413 DOI: 10.1021/Jm00004A011 |
0.488 |
|
| 1995 |
Hjorth S, Suchowski CS, Galloway MP. Evidence for 5-HT autoreceptor-mediated, nerve impulse-independent, control of 5-HT synthesis in the rat brain. Synapse (New York, N.Y.). 19: 170-6. PMID 7784957 DOI: 10.1002/syn.890190304 |
0.668 |
|
| 1995 |
Zhang J, Engel JA, Hjorth S, Svensson L. Changes in the acoustic startle response and prepulse inhibition of acoustic startle in rats after local injection of pertussis toxin into the ventral tegmental area. Psychopharmacology. 119: 71-8. PMID 7675952 DOI: 10.1007/BF02246056 |
0.638 |
|
| 1995 |
Auerbach SB, Lundberg JF, Hjorth S. Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration. Neuropharmacology. 34: 89-96. PMID 7623967 DOI: 10.1016/0028-3908(94)00137-H |
0.455 |
|
| 1995 |
Hjorth S, Bengtsson HJ, Milano S, Lundberg JF, Sharp T. Studies on the role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--I. BMY7378 and prazosin. Neuropharmacology. 34: 615-20. PMID 7566497 DOI: 10.1016/0028-3908(95)00038-8 |
0.488 |
|
| 1995 |
Bergqvist PB, Vogels BA, Bosman DK, Maas MA, Hjorth S, Chamuleau RA, Bengtsson F. Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt. Journal of Neurochemistry. 64: 1238-44. PMID 7532208 DOI: 10.1046/J.1471-4159.1995.64031238.X |
0.465 |
|
| 1994 |
Hjorth S, Auerbach SB. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors. European Journal of Pharmacology. 260: 251-5. PMID 7988652 DOI: 10.1016/0014-2999(94)90346-8 |
0.477 |
|
| 1994 |
Hjorth S, Auerbach SB. Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis. Neuropharmacology. 33: 331-4. PMID 7984270 DOI: 10.1016/0028-3908(94)90062-0 |
0.37 |
|
| 1994 |
McRae A, Ling EA, Hjorth S, Dahlström A, Mason D, Tice T. Catecholamine-containing biodegradable microsphere implants as a novel approach in the treatment of CNS neurodegenerative disease. A review of experimental studies in DA-lesioned rats. Molecular Neurobiology. 9: 191-205. PMID 7888096 DOI: 10.1007/BF02816119 |
0.378 |
|
| 1994 |
Hoffmann P, Elam M, Thorén P, Hjorth S. Effects of long-lasting voluntary running on the cerebral levels of dopamine, serotonin and their metabolites in the spontaneously hypertensive rat. Life Sciences. 54: 855-61. PMID 7511199 DOI: 10.1016/0024-3205(94)00622-9 |
0.366 |
|
| 1993 |
Hjorth S. Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. Journal of Neurochemistry. 60: 776-9. PMID 8419553 DOI: 10.1111/J.1471-4159.1993.Tb03217.X |
0.446 |
|
| 1993 |
Galloway MP, Suchowski CS, Keegan MJ, Hjorth S. Local infusion of the selective 5HT-1b agonist CP-93,129 facilitates striatal dopamine release in vivo. Synapse (New York, N.Y.). 15: 90-2. PMID 8310427 DOI: 10.1002/syn.890150109 |
0.692 |
|
| 1993 |
Hjorth S, Sharp T. In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. The Journal of Pharmacology and Experimental Therapeutics. 265: 707-12. PMID 8098761 |
0.397 |
|
| 1993 |
Sharp T, McQuade R, Bramwell S, Hjorth S. Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology. 348: 339-46. PMID 7904048 DOI: 10.1007/Bf00171331 |
0.38 |
|
| 1993 |
Söderpalm B, Lundin B, Hjorth S. Sustained 5-hydroxytryptamine release-inhibitory and anxiolytic-like action of the partial 5-HT1A receptor agonist, buspirone, after prolonged chronic administration. European Journal of Pharmacology. 239: 69-73. PMID 7901030 DOI: 10.1016/0014-2999(93)90977-P |
0.419 |
|
| 1993 |
Hjorth S, Pettersson G. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo. European Journal of Pharmacology. 238: 357-67. PMID 7691622 DOI: 10.1016/0014-2999(93)90867-H |
0.509 |
|
| 1993 |
Höök BB, Johansson AM, Hjorth S, Sundell S, Hacksell U. Synthesis of (+)-(R)- and (-)-(S)-5-hydroxy-2-methyl-2-dipropylaminotetralin: effects on rat hippocampal output of 5-HT, 5-HIAA, and DOPAC as determined by in vivo microdialysis. Chirality. 5: 112-9. PMID 7687852 DOI: 10.1002/chir.530050303 |
0.416 |
|
| 1993 |
Andersson B, Wikström H, Hjorth S, Svensson K, Carlsson A, Sundell S, Lundmark M, Largent B. Resolved 2-arylcyclohexylamines: Effects on reserpine akinesia and central nervous system monoamine synthesis European Journal of Medicinal Chemistry. 28: 63-69. DOI: 10.1016/0223-5234(93)90079-T |
0.51 |
|
| 1992 |
Hjorth S. Acute reserpine treatment increases rat brain serotonin synthesis via a nerve impulse-dependent mechanism. Journal of Neurochemistry. 58: 772-5. PMID 1530868 DOI: 10.1111/J.1471-4159.1992.Tb09785.X |
0.473 |
|
| 1992 |
Hjorth S. (-)-Penbutolol as a blocker of central 5-HT1A receptor-mediated responses. European Journal of Pharmacology. 222: 121-7. PMID 1468487 DOI: 10.1016/0014-2999(92)90471-F |
0.533 |
|
| 1992 |
Tao R, Hjorth S. Differences in the in vitro and in vivo 5-hydroxytryptamine extraction performance among three common microdialysis membranes. Journal of Neurochemistry. 59: 1778-85. PMID 1383427 DOI: 10.1111/j.1471-4159.1992.tb11010.x |
0.392 |
|
| 1992 |
Nissbrandt H, Hjorth S. Dopaminergic neurotransmission in somatodendritic and terminal areas of the rat brain: susceptibility to modulation by D1 and D2 receptors and to axotomy. Journal of Neural Transmission. General Section. 90: 13-26. PMID 1361343 DOI: 10.1007/BF01250514 |
0.399 |
|
| 1992 |
McRae A, Hjorth S, Dahlström A, Dillon L, Mason D, Tice T. Dopamine fiber growth induction by implantation of synthetic dopamine-containing microspheres in rats with experimental hemi-parkinsonism. Molecular and Chemical Neuropathology / Sponsored by the International Society For Neurochemistry and the World Federation of Neurology and Research Groups On Neurochemistry and Cerebrospinal Fluid. 16: 123-41. PMID 1355653 DOI: 10.1007/BF03159965 |
0.436 |
|
| 1992 |
Tao R, Hjorth S. Alpha 2-adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology. 345: 137-43. PMID 1349158 DOI: 10.1007/BF00165728 |
0.448 |
|
| 1992 |
Nissbrandt H, Waters N, Hjorth S. The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology. 346: 12-9. PMID 1328893 DOI: 10.1007/BF00167564 |
0.603 |
|
| 1991 |
Hjorth S. Single-dose 8-OH-DPAT pretreatment does not induce tachyphylaxis to the 5-HT release-reducing effect of 5-HT1A autoreceptor agonists. European Journal of Pharmacology. 199: 237-42. PMID 1835441 DOI: 10.1016/0014-2999(91)90463-Z |
0.541 |
|
| 1991 |
Hjorth S, Sharp T. Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sciences. 48: 1779-86. PMID 1826937 DOI: 10.1016/0024-3205(91)90216-X |
0.463 |
|
| 1991 |
Hjorth S, Tao R. The putative 5-HT1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969. European Journal of Pharmacology. 209: 249-52. PMID 1797566 DOI: 10.1016/0014-2999(91)90177-R |
0.515 |
|
| 1991 |
Ahlenius S, Hillegaart V, Hjorth S, Larsson K. Effects of sexual interactions on the in vivo rate of monoamine synthesis in forebrain regions of the male rat. Behavioural Brain Research. 46: 117-22. PMID 1786120 DOI: 10.1016/S0166-4328(05)80104-4 |
0.378 |
|
| 1991 |
McRae A, Hjorth S, Mason DW, Dillon L, Tice TR. Microencapsulated dopamine (DA)-induced restitution of function in 6-OHDA-denervated rat striatum in vivo: comparison between two microsphere excipients. Journal of Neural Transplantation & Plasticity. 2: 165-73. PMID 1782252 DOI: 10.1155/NP.1991.165 |
0.416 |
|
| 1990 |
McRae A, Hjorth S, Mason D, Dillon L, Tice T. Implantable microencapsulated dopamine (DA): prolonged functional release of DA in denervated striatal tissue. Journal of Neural Transmission. Supplementum. 29: 207-15. PMID 2358802 DOI: 10.1007/978-3-7091-9050-0_20 |
0.394 |
|
| 1990 |
Hjorth S, Sharp T. Mixed agonist/antagonist properties of NAN-190 at 5-HT1A receptors: behavioural and in vivo brain microdialysis studies. Life Sciences. 46: 955-63. PMID 2329921 DOI: 10.1016/0024-3205(90)90097-B |
0.532 |
|
| 1990 |
Sharp T, Hjorth S. Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor. Journal of Neuroscience Methods. 34: 83-90. PMID 2259248 DOI: 10.1016/0165-0270(90)90045-H |
0.507 |
|
| 1990 |
Hillegaart V, Hjorth S, Ahlenius S. Effects of 5-HT and 8-OH-DPAT on forebrain monoamine synthesis after local application into the median and dorsal raphe nuclei of the rat. Journal of Neural Transmission. General Section. 81: 131-45. PMID 2141990 DOI: 10.1007/BF01245833 |
0.472 |
|
| 1990 |
Sharp T, Backus LI, Hjorth S, Bramwell SR, Grahame-Smith DG. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378. European Journal of Pharmacology. 176: 331-40. PMID 1970304 DOI: 10.1016/0014-2999(90)90027-4 |
0.401 |
|
| 1990 |
Gartside SE, Cowen PJ, Hjorth S. Effects of MDL 73005EF on central pre- and postsynaptic 5-HT1A receptor function in the rat in vivo. European Journal of Pharmacology. 191: 391-400. PMID 1964908 DOI: 10.1016/0014-2999(90)94173-U |
0.555 |
|
| 1990 |
Hjorth S, Sharp T, Liu Y. cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors. An in vivo brain microdialysis study. Naunyn-Schmiedeberg's Archives of Pharmacology. 341: 149-57. PMID 1692973 DOI: 10.1007/Bf00169724 |
0.505 |
|
| 1990 |
Hacksell U, Arvidsson LE, Johansson AM, Karlén A, Luthman K, Hjorth S. Stereoselectivity of Drug Receptor Interactions Drug Information Journal. 24: 485-496. DOI: 10.1177/009286159002400306 |
0.472 |
|
| 1989 |
Sharp T, Bramwell SR, Hjorth S, Grahame-Smith DG. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. British Journal of Pharmacology. 98: 989-97. PMID 2574066 DOI: 10.1111/J.1476-5381.1989.Tb14630.X |
0.417 |
|
| 1989 |
Söderpalm B, Hjorth S, Engel JA. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test. Pharmacology, Biochemistry, and Behavior. 32: 259-65. PMID 2567524 DOI: 10.1016/0091-3057(89)90242-6 |
0.583 |
|
| 1989 |
Nissbrandt H, Sundström E, Jonsson G, Hjorth S, Carlsson A. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum. Journal of Neurochemistry. 52: 1170-82. PMID 2564423 DOI: 10.1111/J.1471-4159.1989.Tb01863.X |
0.615 |
|
| 1989 |
Hjorth S, Sharp T, Hacksell U. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3. European Journal of Pharmacology. 170: 269-74. PMID 2533557 DOI: 10.1016/0014-2999(89)90549-9 |
0.503 |
|
| 1989 |
Hillegaart V, Hjorth S. Median raphe, but not dorsal raphe, application of the 5-HT1A agonist 8-OH-DPAT stimulates rat motor activity. European Journal of Pharmacology. 160: 303-7. PMID 2527161 DOI: 10.1016/0014-2999(89)90505-0 |
0.485 |
|
| 1988 |
Arvidsson LE, Johansson AM, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Magnusson T, Carlsson A, Lindberg P, Andersson B. N,N-Dialkylated monophenolic trans-2-phenylcyclopropylamines: novel central 5-hydroxytryptamine receptor agonists. Journal of Medicinal Chemistry. 31: 92-9. PMID 3336037 |
0.588 |
|
| 1988 |
Hjorth S, Clark D, Carlsson A. Dopamine (DA) autoreceptor efficacy of 3-PPP enantiomers after short-term synaptic DA deprivation. European Journal of Pharmacology. 152: 207-15. PMID 3146512 DOI: 10.1016/0014-2999(88)90715-7 |
0.676 |
|
| 1988 |
McRae-Degueurce A, Hjorth S, Dillon DL, Mason DW, Tice TR. Implantable microencapsulated dopamine (DA): a new approach for slow-release DA delivery into brain tissue. Neuroscience Letters. 92: 303-9. PMID 3143953 DOI: 10.1016/0304-3940(88)90607-6 |
0.369 |
|
| 1988 |
Hajos M, Hjorth S, Svensson K, Carlsson A. In vivo dopamine (DA) receptor binding and behavioural effects of the putative DA autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 in rats with a unilateral nigral 6-OH-DA lesion. Experimental Brain Research. 70: 577-84. PMID 3133239 DOI: 10.1007/BF00247605 |
0.607 |
|
| 1988 |
Hjorth S, Carlsson A. In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390. Journal of Neural Transmission. 72: 83-97. PMID 2968439 DOI: 10.1007/BF01250232 |
0.61 |
|
| 1988 |
White FJ, Bednarz LM, Wachtel SR, Hjorth S, Brooderson RJ. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors? Pharmacology, Biochemistry, and Behavior. 30: 189-93. PMID 2902644 DOI: 10.1016/0091-3057(88)90442-X |
0.377 |
|
| 1988 |
Hjorth S, Magnusson T. The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology. 338: 463-71. PMID 2469021 DOI: 10.1007/BF00179315 |
0.389 |
|
| 1987 |
Johansson AM, Nilsson JL, Karlén A, Hacksell U, Sanchez D, Svensson K, Hjorth S, Carlsson A, Sundell S, Kenne L. C1- and C3-methyl-substituted derivatives of 7-hydroxy-2-(di-n-propylamino)tetralin: activities at central dopamine receptors. Journal of Medicinal Chemistry. 30: 1827-37. PMID 3656358 DOI: 10.1021/JM00393A025 |
0.58 |
|
| 1987 |
Ahlenius S, Carlsson A, Hillegaart V, Hjorth S, Larsson K. Region-selective activation of brain monoamine synthesis by sexual activity in the male rat. European Journal of Pharmacology. 144: 77-82. PMID 3436362 DOI: 10.1016/0014-2999(87)90011-2 |
0.562 |
|
| 1987 |
Hjorth S, Carlsson A, Engel JA. Anxiolytic-like action of the 3-PPP enantiomers in the Vogel conflict paradigm. Psychopharmacology. 92: 371-5. PMID 3114790 DOI: 10.1007/BF00210846 |
0.682 |
|
| 1987 |
Arvidsson LE, Johansson AM, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Magnusson T, Carlsson A, Andersson B, Wikström H. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist. Journal of Medicinal Chemistry. 30: 2105-9. PMID 2959776 DOI: 10.1021/Jm00394A029 |
0.656 |
|
| 1987 |
Fernández-Guasti A, Ahlenius S, Hjorth S, Larsson K. Separation of dopaminergic and serotonergic inhibitory mechanisms in the mediation of estrogen-induced lordosis behaviour in the rat. Pharmacology, Biochemistry, and Behavior. 27: 93-8. PMID 2956611 DOI: 10.1016/0091-3057(87)90482-5 |
0.553 |
|
| 1987 |
Hjorth S, Carlsson A. Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393. Psychopharmacology. 93: 534-7. PMID 2893419 DOI: 10.1007/BF00207249 |
0.606 |
|
| 1987 |
Hjorth S, Söderpalm B, Engel JA. Biphasic effect of L-5-HTP in the Vogel conflict model. Psychopharmacology. 92: 96-9. PMID 2885883 DOI: 10.1007/BF00215486 |
0.549 |
|
| 1987 |
Hajós M, Hjorth S, Carlsson A. Injection of capsaicin into the nucleus raphe dorsalis elicits heat loss in the rat. Neuroscience Letters. 75: 199-204. PMID 2437500 DOI: 10.1016/0304-3940(87)90297-7 |
0.503 |
|
| 1986 |
Svensson K, Carlsson M, Carlsson A, Hjorth S, Johansson AM, Eriksson E. The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats. European Journal of Pharmacology. 130: 237-42. PMID 3792447 DOI: 10.1016/0014-2999(86)90273-6 |
0.703 |
|
| 1986 |
Hjorth S, Svensson K, Carlsson A, Wikström H, Andersson B. Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP. Naunyn-Schmiedeberg's Archives of Pharmacology. 333: 205-18. PMID 3762735 DOI: 10.1007/Bf00512931 |
0.648 |
|
| 1986 |
Hjorth S, Eriksson E, Andersson B. Stereoselective inhibition of prolactin secretion by (-)-HW-165, a novel 3-PPP congener; further support for similarities between central DA autoreceptors and pituitary lactotroph DA receptors. European Journal of Pharmacology. 125: 421-8. PMID 3755402 DOI: 10.1016/0014-2999(86)90798-3 |
0.568 |
|
| 1986 |
Svensson K, Hjorth S, Clark D, Carlsson A, Wikström H, Andersson B, Sanchez D, Johansson AM, Arvidsson LE, Hacksell U. (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors. Journal of Neural Transmission. 65: 1-27. PMID 3083041 DOI: 10.1007/BF01249608 |
0.656 |
|
| 1986 |
Hjorth S, Engel JA, Carlsson A. Anticonflict effects of low doses of the dopamine agonist apomorphine in the rat. Pharmacology, Biochemistry, and Behavior. 24: 237-40. PMID 3006085 DOI: 10.1016/0091-3057(86)90344-8 |
0.696 |
|
| 1986 |
Ahlenius S, Fernandez-Guasti A, Hjorth S, Larsson K. Suppression of lordosis behavior by the putative 5-HT receptor agonist 8-OH-DPAT in the rat. European Journal of Pharmacology. 124: 361-3. PMID 2942412 DOI: 10.1016/0014-2999(86)90241-4 |
0.519 |
|
| 1986 |
Hjorth S, Carlsson A. Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? European Journal of Pharmacology. 129: 131-8. PMID 2429847 DOI: 10.1016/0014-2999(86)90344-4 |
0.648 |
|
| 1985 |
Hjorth S, Carlsson A, Clark D, Svensson K, Sanchez D. Dopamine receptor-mediated hypothermia induced in rats by (+)-, but not by (-)-3-PPP. European Journal of Pharmacology. 107: 299-304. PMID 3979430 DOI: 10.1016/0014-2999(85)90254-7 |
0.717 |
|
| 1985 |
Wikström H, Andersson B, Sanchez D, Lindberg P, Arvidsson LE, Johansson AM, Nilsson JL, Svensson K, Hjorth S, Carlsson A. Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists. Journal of Medicinal Chemistry. 28: 215-25. PMID 3968686 DOI: 10.1021/Jm00380A012 |
0.653 |
|
| 1985 |
Hjorth S, Clark D, Svensson K, Carlsson A, Thorberg O. Sub-chronic administration of (-)-3-PPP and central dopamine receptor sensitivity changes. Journal of Neural Transmission. 64: 187-98. PMID 3936899 DOI: 10.1007/Bf01256466 |
0.597 |
|
| 1985 |
Johansson AM, Arvidsson LE, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Clark D, Carlsson A, Sanchez D, Andersson B. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors. Journal of Medicinal Chemistry. 28: 1049-53. PMID 3927002 |
0.484 |
|
| 1985 |
Clark D, Hjorth S, Carlsson A. Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence. Journal of Neural Transmission. 62: 1-52. PMID 3894582 DOI: 10.1007/Bf01260414 |
0.682 |
|
| 1985 |
Hjorth S, Carlsson A. (-)-Pindolol stereospecifically inhibits rat brain serotonin (5-HT) synthesis. Neuropharmacology. 24: 1143-6. PMID 2867485 DOI: 10.1016/0028-3908(85)90207-2 |
0.577 |
|
| 1985 |
Clark D, Hjorth S, Carlsson A. Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. Journal of Neural Transmission. 62: 171-207. PMID 2863323 DOI: 10.1007/Bf01252236 |
0.658 |
|
| 1985 |
Gradin K, Pettersson A, Hjorth S, Hedner T, Arvidsson LE, Persson B. Cardiovascular effects in the Sprague-Dawley rat of 8-hydroxy-2(di-N-propylamino) tetralin, a selective 5-hydroxytryptamine receptor agonist. The Journal of Pharmacy and Pharmacology. 37: 263-5. PMID 2860226 |
0.402 |
|
| 1985 |
Hjorth S, Clark D, Carlsson A. Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: discrepancies between in vitro and in vivo observations. Life Sciences. 37: 673-84. PMID 2410756 DOI: 10.1016/0024-3205(85)90435-7 |
0.695 |
|
| 1985 |
Johansson AM, Arvidsson L-, Hacksell U, Nilsson JLG, Svensson K, Hjorth S, Clark D, Carlsson A, Sanchez D, Andersson B, Wikstroem H. Novel Dopamine Receptor Agonists And Antagonists With Preferential Action On Autoreceptors Cheminform. 16. DOI: 10.1002/Chin.198548162 |
0.663 |
|
| 1985 |
Wikstroem H, Andersson B, Sanchez D, Lindberg P, Arvidsson L-, Johansson AM, Nilsson JLG, Svensson K, Hjorth S, Carlsson A. Resolved Monophenolic 2-Aminotetralins And 1,2,3,4,4A,5,6,10B-Octahydrobenzo(F)Quinolines: Structural And Stereochemical Considerations For Centrally Acting Pre- And Postsynaptic Dopamine-Receptor Agonists Cheminform. 16. DOI: 10.1002/Chin.198524182 |
0.579 |
|
| 1985 |
Wikstroem H, Sanchez D, Lindberg P, Hacksell U, Arvidsson L-, Johansson AM, Thorberg S-, Nilsson JLG, Svensson K, Hjorth S, Clark D, Carlsson A. Resolved 3-(3-Hydroxyphenyl)-N-N-Propylpiperidine And Its Analogs: Central Dopamine Receptor Activity Cheminform. 16. DOI: 10.1002/Chin.198503222 |
0.597 |
|
| 1985 |
Hacksell U, Johansson AM, Arvidsson L-, Nilsson JLG, Hjorth S, Carlsson A, Wikstroem H, Sanchez D, Lindberg P. C1-Methylated 5-Hydroxy-2-(Dipropylamino)Tetralins: Central Dopamine-Receptor Stimulating Activity Cheminform. 16. DOI: 10.1002/Chin.198503183 |
0.605 |
|
| 1984 |
Hacksell U, Johansson AM, Arvidsson L, Nilsson JL, Hjorth S, Carlsson A, Wikström H, Sanchez D, Lindberg P. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity. Journal of Medicinal Chemistry. 27: 1003-7. PMID 6431102 DOI: 10.1021/Jm00374A012 |
0.669 |
|
| 1984 |
Arvidsson LE, Hacksell U, Johansson AM, Nilsson JL, Lindberg P, Sanchez D, Wikström H, Svensson K, Hjorth S, Carlsson A. 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists. Journal of Medicinal Chemistry. 27: 45-51. PMID 6418888 DOI: 10.1021/Jm00367A009 |
0.664 |
|
| 1984 |
Schorderet M, Hjorth S, Hacksell U. Differential effects of the enantiomers of 3-PPP on dopamine D1-receptors of isolated rabbit retina. Journal of Neural Transmission. 59: 1-7. PMID 6325591 |
0.409 |
|
| 1984 |
Engel JA, Hjorth S, Svensson K, Carlsson A, Liljequist S. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). European Journal of Pharmacology. 105: 365-8. PMID 6239785 DOI: 10.1016/0014-2999(84)90634-4 |
0.729 |
|
| 1984 |
Clark D, Hjorth S, Carlsson A. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis. European Journal of Pharmacology. 106: 185-9. PMID 6099268 DOI: 10.1016/0014-2999(84)90694-0 |
0.641 |
|
| 1984 |
Hjorth S, Neumeyer JL. Central monoaminergic effects of two aporphine analogues to the putative serotonin-receptor agonist, 8-hydroxy-2-di-n-propylaminotetralin. Neuropharmacology. 23: 1187-90. PMID 6097834 DOI: 10.1016/0028-3908(84)90237-5 |
0.459 |
|
| 1984 |
Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson LE, Johansson AM, Thorberg SO, Nilsson JL, Svensson K, Hjorth S. Resolved 3-(3-hydroxyphenyl)-N-n-propylpiperidine and its analogues: central dopamine receptor activity. Journal of Medicinal Chemistry. 27: 1030-6. PMID 6086923 |
0.405 |
|
| 1984 |
Arvidsson L-, Hacksell U, Johansson AM, Nilsson JLG, Lindberg P, Sanchez D, Wikstroem H, Svensson K, Hjorth S, Carlsson A. 8-Hydroxy-2-(Alkylamino)Tetralins And Related Compounds As Central 5-Hydroxytryptamine Receptor Agonists Cheminform. 15. DOI: 10.1002/Chin.198424168 |
0.584 |
|
| 1983 |
Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson LE, Johansson A, Nilsson JL. The search for selective dopaminergic autoreceptor agonists. Journal of Neural Transmission. Supplementum. 18: 131-7. PMID 6576112 |
0.482 |
|
| 1983 |
Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson LE, Johansson A. Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP. Psychopharmacology. 81: 89-99. PMID 6415751 DOI: 10.1007/BF00428999 |
0.63 |
|
| 1983 |
Clark D, Carlsson A, Hjorth S, Engel J, Lindberg P. The effect of the enantiomers of 3-PPP on conditioned avoidance responding in the rat. Psychopharmacology. 81: 14-7. PMID 6138790 DOI: 10.1007/BF00439266 |
0.741 |
|
| 1983 |
Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson L-, Johansson A, Nilsson JLG. The search for selective dopaminergic autoreceptor agonists. Journal of Neural Transmission-Supplement. 18: 131-137. DOI: 10.1007/978-3-7091-4408-4_12 |
0.662 |
|
| 1983 |
Wikstroem H, Sanchez D, Lindberg P, Arvidsson L-, Hacksell U, Johansson A, Nilsson JLG, Hjorth S, Carlsson A. Monophenolic Octahydrobenzo(F)Quinolines: Central Dopamine- And Serotonin-Receptor Stimulating Activity Cheminform. 14. DOI: 10.1002/Chin.198303246 |
0.624 |
|
| 1982 |
Wikström H, Sanchez D, Lindberg P, Arvidsson LE, Hacksell U, Johansson A, Nilsson JL, Hjorth S, Carlsson A. Monophenolic octahydrobenzo[f]quinolines: central dopamine- and serotonin-receptor stimulating activity. Journal of Medicinal Chemistry. 25: 925-31. PMID 6811743 |
0.388 |
|
| 1982 |
Jackson D, Carlsson A, Hjorth S, Lindberg P. A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine). Journal of Neural Transmission. 53: 233-45. PMID 6286867 DOI: 10.1007/Bf01252035 |
0.612 |
|
| 1982 |
Hjorth S, Carlsson A. Buspirone: effects on central monoaminergic transmission--possible relevance to animal experimental and clinical findings. European Journal of Pharmacology. 83: 299-303. PMID 6129148 DOI: 10.1016/0014-2999(82)90265-5 |
0.652 |
|
| 1982 |
Clark D, Carlsson A, Hjorth S, Svensson K, Engel J, Sanchez D. Is 3-PPP a potential antipsychotic agent? Evidence from animal behavioral studies. European Journal of Pharmacology. 83: 131-4. PMID 6127226 DOI: 10.1016/0014-2999(82)90297-7 |
0.696 |
|
| 1982 |
Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikström H, Arvidsson LE, Hacksell U, Nilsson JLG. 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity Journal of Neural Transmission. 55: 169-188. DOI: 10.1007/Bf01276574 |
0.651 |
|
| 1982 |
Hacksell U, Arvidsson L-, Svensson U, Nilsson JLG, Sanchez D, Wikstroem H, Lindberg P, Hjorth S, Carlsson A. 3-Phenylpiperidines. Central Dopamine-Autoreceptor Stimulating Activity Cheminform. 13. DOI: 10.1002/Chin.198222234 |
0.577 |
|
| 1982 |
Arvidsson L-, Hacksell U, Nilsson JLG, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikstroem H. 8-Hydroxy-2-(Dipropylamino)Tetralin, A New Centrally Acting 5-Hydroxytryptamine Receptor Agonist Cheminform. 13. DOI: 10.1002/Chin.198203137 |
0.606 |
|
| 1981 |
Hacksell U, Arvidsson LE, Svensson U, Nilsson JL, Wikström H, Lindberg P, Sanchez D, Hjorth S, Carlsson A, Paalzow L. Monophenolic 2-(dipropylamino)indans and related compounds: central dopamine-receptor stimulating activity. Journal of Medicinal Chemistry. 24: 429-34. PMID 7265130 DOI: 10.1021/Jm00136A012 |
0.637 |
|
| 1981 |
Arvidsson LE, Hacksell U, Nilsson JL, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikstrom H. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. Journal of Medicinal Chemistry. 24: 921-3. PMID 6460101 DOI: 10.1021/Jm00140A002 |
0.601 |
|
| 1981 |
Ahlenius S, Larsson K, Svensson L, Hjorth S, Carlsson A, Lindberg P, Wikström H, Sanchez D, Arvidsson LE, Hacksell U, Nilsson JL. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacology, Biochemistry, and Behavior. 15: 785-92. PMID 6458826 DOI: 10.1016/0091-3057(81)90023-X |
0.577 |
|
| 1981 |
Hjorth S, Carlsson A, Wikström H, Lindberg P, Sanchez D, Hacksell U, Arvidsson LE, Svensson U, Nilsson JL. 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors. Life Sciences. 28: 1225-38. PMID 6112651 DOI: 10.1016/0024-3205(81)90448-3 |
0.683 |
|
| 1981 |
Hacksell U, Arvidsson L-, Svensson U, Nilsson JLG, Wikstroem H, Lindberg P, Sanchez D, Hjorth S, Carlsson A, Paalzow L. Monophenolic 2-(Dipropylamino)Indans And Related Compounds: Central Dopamine-Receptor Stimulating Activity Cheminform. 12. DOI: 10.1002/Chin.198134192 |
0.62 |
|
| 1980 |
Hjorth S, Carlsson A, Lindberg P. A new centrally acting DA-receptor agonist with selectivity for autoreceptors. Psychopharmacology Bulletin. 16: 85-90. PMID 7403415 |
0.422 |
|
| 1980 |
Hacksell U, Svensson U, Nilsson JLG, Hjorth S, Carlsson A, Wikstroem H, Lindberg P, Sanchez D. N-Alkylated 2-Aminotetralins: Central Dopamine-Receptor Stimulating Activity Cheminform. 11. DOI: 10.1002/Chin.198015191 |
0.628 |
|
| 1979 |
Hacksell U, Svensson U, Nilsson JL, Hjorth S, Carlsson A, Wikström H, Lindenberg P, Sanchez D. N-Alkylated 2-aminotetralins: central dopamine-receptor stimulating activity. Journal of Medicinal Chemistry. 22: 1469-75. PMID 317109 |
0.32 |
|
| 1979 |
Wikstroem H, Lindberg P, Martinson P, Hjorth S, Carlsson A, Hacksell U, Svensson U, Nilsson JLG. Pivaloyl Esters Of N,N‐Dialkylated Dopamine Congeners. Central Dopamine‐Receptor Stimulating Activity Cheminform. 10. DOI: 10.1002/Chin.197908144 |
0.575 |
|
| Show low-probability matches. |